PRPH Competitors & Alternatives
Compare ProPhase Labs Inc with similar stocks in the same industry
Diagnostics & Research
PRPH
Main Stock$0.36
Tradestie Score
56
Market Cap
$21.41M
Revenue Growth
-0.4%
Analyst Upside
+3705.8%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$11.13
|
$1.13B | - | 55 | Compare |
|
CDNA
CareDx, Inc.
|
$26.18
|
$798.40M | - | 66 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$18.00
|
$719.31M | - | 47 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$21.12
|
$667.77M | - | 52 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$10.54
|
$612.76M | - | 54 | Compare |
|
ICCC
Immucell Corp
|
$9.49
|
$59.70M | - | 55 | Compare |
|
CPIX
Cumberland Pharmaceuticals Inc
|
$5.72
|
$46.68M | - | 57 | Compare |
|
NAII
Natural Alternatives International Inc.
|
$2.67
|
$17.91M | - | 58 | Compare |
|
XTLB
XTL Biopharmaceuticals Ltd. American Depositary Shares
|
$2.54
|
$10.14M | - | 52 | Compare |
|
SNOA
Sonoma Pharmaceuticals, Inc. Common Stock
|
$1.15
|
$6.37M | - | 48 | Compare |
More PRPH Analysis
Data updated: Jun 19, 2026 | Industry: Diagnostics & Research (SIC 2834)
39 stocks in this industry